PH22534A - Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide - Google Patents

Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide

Info

Publication number: PH22534A
Authority: PH; Philippines
Prior art keywords: ribofuranosyl; carboxamide; triazole; medical treatment; viral diseases
Prior art date: 1984-10-29

Application number

PH32282A

Other languages

English (en)

Inventor

Smith Roberts Angus

Fernandez Humberto

Original Assignee

Vira Tek Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-29

Filing date

1985-05-16

Publication date

1988-10-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH22534(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-05-16 Application filed by Vira Tek Inc filed Critical Vira Tek Inc

1988-10-17 Publication of PH22534A publication Critical patent/PH22534A/en

Links

201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
230000003612 virological effect Effects 0.000 title abstract 2
IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title 1
241000725643 Respiratory syncytial virus Species 0.000 abstract 2
241000700605 Viruses Species 0.000 abstract 2
241000712891 Arenavirus Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
241000713112 Orthobunyavirus Species 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000002831 pharmacologic agent Substances 0.000 abstract 1
241001430294 unidentified retrovirus Species 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PH32282A 1984-10-29 1985-05-16 Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide PH22534A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66625284A	1984-10-29	1984-10-29

Publications (1)

Publication Number	Publication Date
PH22534A true PH22534A (en)	1988-10-17

Family

ID=24673430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH32282A PH22534A (en)	1984-10-29	1985-05-16	Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide

Country Status (18)

Country	Link
EP (3)	EP0181050A3 (fr)
JP (1)	JPH0713019B2 (fr)
KR (1)	KR860003018A (fr)
AT (1)	ATE204173T1 (fr)
AU (1)	AU584333B2 (fr)
BE (1)	BE902199A (fr)
CA (1)	CA1261265A (fr)
DD (1)	DD261094A5 (fr)
DE (3)	DE10299005I2 (fr)
ES (1)	ES8704962A1 (fr)
FR (1)	FR2572286B1 (fr)
GB (1)	GB2166050B (fr)
LU (1)	LU85854A1 (fr)
NL (1)	NL300083I1 (fr)
NZ (1)	NZ212510A (fr)
PH (1)	PH22534A (fr)
PT (1)	PT81387B (fr)
ZA (1)	ZA858237B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3650377T2 (de) *	1985-12-23	1996-02-22	Hutchinson Fred Cancer Res	Regulierung der retroviralen replikation, infektion und pathogenese.
JP2792246B2 (ja) *	1991-01-31	1998-09-03	信越半導体株式会社	単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
IL144130A0 (en) *	1999-01-29	2002-05-23	Icn Pharmaceuticals	Modulation of immune response by ribavirin
US6720000B2 (en)	2001-03-19	2004-04-13	Three Rivers Pharmaceutical, Llc	Process for producing wet ribavirin pellets
US7132453B2 (en) *	2002-03-15	2006-11-07	Vanderbilt University	Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en)	2002-09-19	2009-05-26	Three Rivers Pharmacueticals, Llc	Composition containing ribavirin and use thereof
US20170112867A1 (en)	2014-06-23	2017-04-27	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Pharmaceutical combinations of sofosbuvir and ribavirin
US20170151272A1 (en)	2014-06-23	2017-06-01	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	A novel pharmaceutical composition of sofosbuvir and ribavirin
WO2015197535A1 (fr)	2014-06-23	2015-12-30	Sanovel Ilac Sanayi Ve Ticaret A.S.	Compositions pharmaceutiques de sofosbuvir et de ribavirine à libération modifiée
JP2018076280A (ja) *	2016-10-28	2018-05-17	国立大学法人大分大学	ジカウイルス感染症治療用医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3927216A (en) *	1971-06-01	1975-12-16	Icn Pharmaceuticals	1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US3798209A (en) *	1971-06-01	1974-03-19	Icn Pharmaceuticals	1,2,4-triazole nucleosides
US4211771A (en) *	1971-06-01	1980-07-08	Robins Ronald K	Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
AR205339A1 (es) *	1973-03-12	1976-04-30	Icn Pharmaceuticals	Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
AU564876B2 (en) *	1982-03-29	1987-08-27	Liposome Company, Inc., The	Stable plurilamellar vesicles

1985
- 1985-04-15 BE BE0/214849A patent/BE902199A/fr not_active IP Right Cessation
- 1985-04-16 DE DE2002199005 patent/DE10299005I2/de active Active
- 1985-04-16 EP EP85302644A patent/EP0181050A3/fr not_active Withdrawn
- 1985-04-16 EP EP94118300A patent/EP0643970B1/fr not_active Revoked
- 1985-04-16 GB GB8509689A patent/GB2166050B/en not_active Expired
- 1985-04-16 EP EP19900105678 patent/EP0383361A3/fr not_active Withdrawn
- 1985-04-16 AT AT94118300T patent/ATE204173T1/de active
- 1985-04-16 DE DE3588232T patent/DE3588232T2/de not_active Expired - Lifetime
- 1985-04-16 DE DE198585302644T patent/DE181050T1/de active Pending
- 1985-04-17 LU LU85854A patent/LU85854A1/fr unknown
- 1985-04-30 AU AU41807/85A patent/AU584333B2/en not_active Expired
- 1985-05-07 CA CA000480878A patent/CA1261265A/fr not_active Expired
- 1985-05-16 PH PH32282A patent/PH22534A/en unknown
- 1985-05-30 FR FR858508143A patent/FR2572286B1/fr not_active Expired - Fee Related
- 1985-05-30 KR KR1019850003752A patent/KR860003018A/ko not_active Ceased
- 1985-06-05 JP JP60122351A patent/JPH0713019B2/ja not_active Expired - Fee Related
- 1985-06-21 NZ NZ212510A patent/NZ212510A/xx unknown
- 1985-10-09 DD DD85281565A patent/DD261094A5/de active Search and Examination
- 1985-10-28 ZA ZA858237A patent/ZA858237B/xx unknown
- 1985-10-28 PT PT81387A patent/PT81387B/pt active IP Right Revival
- 1985-10-29 ES ES548303A patent/ES8704962A1/es not_active Expired
2002
- 2002-02-14 NL NL300083C patent/NL300083I1/nl unknown

Also Published As

Publication number	Publication date
GB2166050B (en)	1989-08-16
NL300083I1 (nl)	2002-05-01
DE3588232T2 (de)	2002-06-13
DE181050T1 (de)	1986-12-18
HK1010985A1 (en)	1999-07-02
BE902199A (fr)	1985-07-31
PT81387B (pt)	1987-11-11
KR860003018A (ko)	1986-05-19
EP0643970A2 (fr)	1995-03-22
NZ212510A (en)	1989-04-26
ES548303A0 (es)	1987-04-16
EP0643970B1 (fr)	2001-08-16
ZA858237B (en)	1988-02-24
FR2572286A1 (fr)	1986-05-02
JPH0713019B2 (ja)	1995-02-15
DE10299005I2 (de)	2004-07-01
GB2166050A (en)	1986-04-30
DD261094A5 (de)	1988-10-19
LU85854A1 (fr)	1985-12-16
JPS61109723A (ja)	1986-05-28
ATE204173T1 (de)	2001-09-15
PT81387A (en)	1985-11-01
EP0181050A2 (fr)	1986-05-14
FR2572286B1 (fr)	1990-03-23
GB8509689D0 (en)	1985-05-22
AU584333B2 (en)	1989-05-25
EP0383361A2 (fr)	1990-08-22
DE10299005I1 (de)	2002-05-08
AU4180785A (en)	1986-05-08
EP0181050A3 (fr)	1987-10-21
EP0643970A3 (fr)	1997-07-09
ES8704962A1 (es)	1987-04-16
DE3588232D1 (de)	2001-09-20
CA1261265A (fr)	1989-09-26
EP0383361A3 (fr)	1993-06-16

Publication	Publication Date	Title
BR9714363A (pt)	2000-03-21	Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE3579113D1 (de)	1990-09-13	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
MY130035A (en)	2007-05-31	Antiviral compounds
ATE81978T1 (de)	1992-11-15	Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
PH22534A (en)	1988-10-17	Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide
GB9425730D0 (en)	1995-02-22	Compounds
MY124071A (en)	2006-06-30	Treatment of viral disease in swine
DE3462688D1 (en)	1987-04-23	1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
NO965556L (no)	1996-12-23	Trippelkombinasjon mot HIV
DE3378979D1 (en)	1989-02-23	1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
DK664188D0 (da)	1988-11-29	Butylhydroxyanisoler til behandling af retrovirale sygdomme
FI834429A7 (fi)	1984-06-04	3',5'-diarabinosidien valmistus ja terapeuttinen soveltaminen.
TR199901998T2 (xx)	1999-11-22	9,10-sekokolesta-5,7,10(19)-triyen-1,3-diyol veya alfakasidol�n kullan�m�.
UA23352A (uk)	1998-08-31	beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
IT8522576A0 (it)	1985-10-22	Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
FR2786099B1 (fr)	2000-12-29	Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline
ATE179987T1 (de)	1999-05-15	Vitamin b 12-haltige sanddornkonzentrate oder - extrakte
ATE81587T1 (de)	1992-11-15	Medizinisches praeparat zur behandlung von hautleiden.
IS3304A7 (is)	1988-11-28	Aðferð til framleiðslu, notkun og samsetning efnablöndu til meðhöndlunar sóriasis, gigtar eða andarteppusjúkdóma.